Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
Recruiting · NCT05469893 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immuno-PRISM (PRecision Intervention Smoldering Myeloma) | Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, precancerous condition, smoldering plasma cell myeloma, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2026-07-16 | NCT05469893 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Irene Ghobrial, MD | 1 |
| Janssen Research & Development, LLC | 188 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Colorado Blood Cancer Institute | Denver | United States | 178 |
| Dana Farber Cancer Institute | Boston | United States | 133 |
| Oregon Health & Science University | Portland | United States | 261 |